Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0I2FZ
|
|||
| Former ID |
DIB020071
|
|||
| Drug Name |
IRAK-1/4 inhibitor
|
|||
| Synonyms |
IRAK-1-4 Inhibitor I; 509093-47-4; IRAK-1/4 Inhibitor I; IRAK-1/4 Inhibitor; Interleukin-1 Receptor-Associated-Kinase-1/4 Inhibitor; CHEMBL379787; N-(2-Morpholinylethyl)-2-(3-nitrobenzoylamido)-benzimidazole; N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]-3-nitrobenzamide; N-[1-[2-(4-morpholinyl)ethyl]-1H-benzimidazol-2-yl]-3-nitrobenzamide; IRAK-1-4InhibitorI; IRAK1/4 Inhibitor I; MLS006010636; SCHEMBL3600534; GTPL5990; CTK8E9833; DTXSID50475143; QTCFYQHZJIIHBS-UHFFFAOYSA-N; MolPort-028-617-757; HMS3263A20; HMS3229G05
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL
|
||
| Formula |
C20H21N5O4
|
|||
| Canonical SMILES |
C1COCCN1CCN2C3=CC=CC=C3N=C2NC(=O)C4=CC(=CC=C4)[N+](=O)[O-]
|
|||
| InChI |
1S/C20H21N5O4/c26-19(15-4-3-5-16(14-15)25(27)28)22-20-21-17-6-1-2-7-18(17)24(20)9-8-23-10-12-29-13-11-23/h1-7,14H,8-13H2,(H,21,22,26)
|
|||
| InChIKey |
QTCFYQHZJIIHBS-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 509093-47-4
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
17434257, 24494197, 26758965, 37431771, 53800889, 75298096, 90341009, 99302704, 103490415, 104069026, 121361784, 124896723, 124896724, 139392765, 152258544, 160647378, 162248055, 163124745, 163565003, 163687882, 174006735, 175607414, 178102612, 179721404, 184813709, 204370944, 208265099, 223704490, 223819025, 229603153, 247526845, 252437894, 252479210
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4. Bioorg Med Chem Lett. 2006 Jun 1;16(11):2842-5. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.